地屈孕酮
外觀
![]() | |
![]() | |
臨床資料 | |
---|---|
商品名 | Duphaston, others |
其他名稱 | Isopregnenone; Dehydroprogesterone; Didrogesteron; 6-Dehydroretroprogesterone; 9β,10α-Pregna-4,6-diene-3,20-dione; NSC-92336[1][2] |
AHFS/Drugs.com | 國際藥品名稱 |
給藥途徑 | By mouth |
藥物類別 | Progestin; Progestogen |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | 28%[3] |
血漿蛋白結合率 | ? (probably to albumin)[3][4] |
藥物代謝 | Hepatic: AKR1C1, AKR1C3, CYP3A4[7][5] |
代謝產物 | 20α-DHD (exclusively via AKR1C1 and AKRC13)[5] |
生物半衰期 | Parent: 5–7 hours[6] Metabolite: 14–17 hours[6] |
排泄途徑 | Urine |
識別資訊 | |
| |
CAS號 | 152-62-5 ![]() |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.280 |
化學資訊 | |
化學式 | C21H28O2 |
摩爾質量 | 312.446 g/mol |
3D模型(JSmol) | |
熔點 | 144 °C(291 °F) |
沸點 | 463 °C(865 °F) |
水溶性 | Insoluble mg/mL (20 °C) |
| |
|
地屈孕酮(英語:Dydrogesterone,縮寫DYD,商品名為Duphaston等)是一種黃體製劑藥物,用於治療一系列疾病,包括妊娠期的習慣性流產,黃體期缺陷(LPD)造成的功能失調性子宮出血和不孕,經痛,子宮內膜異位症,繼發性閉經,月經周期紊亂,經前綜合症,是激素替代療法的選用藥物之一[4],通常由口服給藥[4]。
參考文獻
[編輯]- ^ J. Elks. The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014: 474– [2019-06-09]. ISBN 978-1-4757-2085-3. (原始內容存檔於2020-08-03).
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000: 378–. ISBN 978-3-88763-075-1.
- ^ 3.0 3.1 ((Howard JA Carp, MB, BS, FRCOG)). Progestogens in Obstetrics and Gynecology. Springer. 9 April 2015: 33, 38. ISBN 978-3-319-14385-9. 溫哥華格式錯誤 (幫助)
- ^ 4.0 4.1 4.2 Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005,. 8 Suppl 1: 3–63. PMID 16112947. doi:10.1080/13697130500148875.
- ^ 5.0 5.1 Beranič, N.; Gobec, S.; Rižner, T. Lanišnik. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3. Chemico-Biological Interactions. 2011, 191 (1–3): 227–233. ISSN 0009-2797. PMID 21182831. doi:10.1016/j.cbi.2010.12.012.
- ^ 6.0 6.1 Bińkowska, Małgorzata; Woroń, Jarosław. Progestogens in menopausal hormone therapy. Menopausal Review. 2015, 14 (2): 134–143. ISSN 1643-8876. PMC 4498031
. PMID 26327902. doi:10.5114/pm.2015.52154.
- ^ Olbrich, Matthias; Weigl, Kevin; Kahler, Elke; Mihara, Katsuhiro. Dydrogesterone metabolism in human liver by aldo-keto reductases and cytochrome P450 enzymes. Xenobiotica. 2016, 46 (10): 868–874. ISSN 0049-8254. PMID 26796435. doi:10.3109/00498254.2015.1134852.